Sight Diagnostics
Sight Diagnostics is an Israeli private VC-backed medtech startup developing AI-powered blood diagnostics using computer vision and machine learning, with dual-use potential in military point-of-care testing.
Visit WebsiteCompany Overview
Sight Diagnostics develops an AI-powered blood analysis platform that uses computer vision and machine learning to perform rapid, accurate blood diagnostics from a small finger-prick sample. The technology analyzes thousands of blood cells in minutes, providing complete blood count results and detecting abnormalities without traditional laboratory infrastructure.
The company has pivoted from its original OLO device to focus on immune cell analysis, decoding live immune cells in action to provide unprecedented clinical insights. The platform generates proprietary data from direct cell observation combined with cutting-edge AI to support clinical decision-making.
Dual-use relevance is strong: portable AI-powered blood diagnostics that operate without traditional laboratory equipment are directly applicable to military point-of-care testing, enabling rapid blood analysis in forward medical stations, field hospitals, and remote deployments where laboratory infrastructure is unavailable.
Dual-Use Assessment
AI-powered portable blood diagnostics have dual-use value for civilian clinical diagnostics and military point-of-care testing in field and austere environments.
Key Technologies
- AI-powered computer vision blood cell analysis
- Rapid finger-prick sample blood diagnostics
- Live immune cell decoding and signature analysis
- Machine learning hematology classification
- Compact point-of-care diagnostic platform
Use Cases & Applications
- Rapid clinical blood count and morphology analysis
- Immune signature profiling for disease detection
- Military field hospital point-of-care blood testing
- Emergency department rapid triage diagnostics
- Remote and underserved area blood diagnostics
Strategic Value to U.S.-Israel Alliance
Enhances allied military medical capability with AI-powered portable blood diagnostics that do not require traditional laboratory infrastructure.
Interested in this startup?
Learn more about our investment approach or get in touch to discuss opportunities in dual-use technology.